Literatur
Stintzing S. TZM-News. 2021;23(2):5-7
André T et al. N Engl J Med. 2020;383(23):2207-8
André T et al. Lancet Oncol. 2021;22(5):655-77
https://euroqol.org/publications/user-guides abgerufen am 23. August 2021
Cohen R et al. Cancers (Basel). 2021;13(5):1149
Overman MJ et al. Lancet Oncol. 2017;18(9):1182-91
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schalhorn, A. Pembrolizumab beim MSI-h-mCRC. InFo Hämatol Onkol 24, 27–28 (2021). https://doi.org/10.1007/s15004-021-8780-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-021-8780-x